Poorly differentiated neoplasms and tumors of unknown origin: introduction.
作者信息
Fer M F, Greco F A, Oldham R K
出版信息
Semin Oncol. 1982 Dec;9(4):393-5.
PMID:7170627
Abstract
摘要
相似文献
1
Poorly differentiated neoplasms and tumors of unknown origin: introduction.
Semin Oncol. 1982 Dec;9(4):393-5.
2
Clinical verification of the performance of the pathwork tissue of origin test: utility and limitations.
Am J Clin Pathol. 2011 Dec;136(6):924-33. doi: 10.1309/AJCPDQPFO73SSNFR.
3
Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapy.
J Clin Oncol. 1987 Aug;5(8):1275-80. doi: 10.1200/JCO.1987.5.8.1275.
4
5
Cancers of unknown origin: current approaches and future perspectives.
Semin Oncol. 1982 Dec;9(4):526-31.
6
[Growth and metastasis of malignant tumors].
Fortschr Med. 1981 Jul 23;99(27-28):1065-9.
7
[Malignant tumors of unknown origin].
Rev Med Liege. 1999 Jan;54(1):39-42.
8
PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
Cancer Cytopathol. 2011 Jun 25;119(3):193-201. doi: 10.1002/cncy.20136. Epub 2011 Feb 15.
9
TESTICULAR TUMORS.
Philipp J Cancer. 1963 Jan-Mar;5:417-22.
10
Metastatic neuroendocrine tumor of unknown primary presenting as acute pancreatitis.
Am J Med Sci. 2008 Apr;335(4):304-6. doi: 10.1097/MAJ.0b013e318156b6f3.
引用本文的文献
1
[Therapy pf cervical lymph node metastases of unknown primary tumor].
Strahlenther Onkol. 1997 Jul;173(7):362-8. doi: 10.1007/BF03038239.
2
Cancer of unknown primary site.
J Cancer Res Clin Oncol. 1991;117(6):505-9. doi: 10.1007/BF01613279.
Zotero 插件